Transcatheter heart valves technologies

Major threats to early safety after transcatheter aortic valve implantation in a contemporary cohort of real-world patients

Published on 08/10/2021 | D. J. van Ginkel 1 et al. | Netherlands heart journal 2021; aop: 10.1007/s12471-021-01638-8 | 17 minute read

Abstract Introduction Despite considerable advances in the last decade, major adverse events remain a concern after transcatheter aortic valve implantation (TAVI).

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.

Transcatheter heart valves technologies

Major threats to early safety after transcatheter aortic valve implantation in a contemporary cohort of real-world patients

Members/My Account

Useful Links

About

Copyright 2025 © GNM Healthcare Group Companies USA, Inc.